Minnesota HF 2637: Provider conflict of interest restrictions for infusion drugs exemption provided.

Status: Introduction and first reading, referred to Commerce (as of 2019-03-20)

State: Minnesota · Session: 2019-2020 · Bill: HF 2637

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Mann, Liebling

View Minnesota HF 2637 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.